Table 2 Liver function parameters in EAC-bearing mice after treatment with amygdalin and/or sorafenib.

44.75 ± 1.26^e,f

59.50 ± 3.87^f

4.34 ± 0.15^a

6.12 ± 0.18^a

19.75 ± 2.01^e

48.25 ± 1.93^e

62.75 ± 2.21^f

3.67 ± 0.11^b

5.15 ± 0.20^d

22.00 ± 2.41^e

56.08 ± 1.58^d

67.00 ± 2.73^e,f

3.62 ± 0.16^b

6.23 ± 0.22^a

35.50 ± 2.75^c,d

54.21 ± 1.35^d

69.21 ± 2.13^e

3.40 ± 0.09^b

5.37 ± 0.17^b,d

33.75 ± 2.75^d

54.03 ± 1.84^d

64.73 ± 2.28^a

4.14 ± 0.13^a

6.05 ± 0.19^a

31.25 ± 3.25^d

57.50 ± 2.21^d

77.50 ± 3.21^d

3.62 ± 0.12^b

5.50 ± 0.11^b

38.00 ± 3.13^c

86.47 ± 3.51^a

165.0 ± 6.72^a

2.35 ± 0.09^d

4.17 ± 0.23^e

154.37 ± 9.21^a

75.61 ± 3.15^b

103.8 ± 5.40^b

3.13 ± 0.24^b

5.65 ± 0.14^b

99.50 ± 7.46^b

50.00 ± 2.38^d,e

74.00 ± 3.80^d,e

3.25 ± 0.11^b

5.70 ± 0.16^b

33.00 ± 2.13^d

66.50 ± 2.49^c

88.00 ± 4.41^c

3.07 ± 0.15^b

5.97 ± 0.24^a,b

46.25 ± 2.80^c

39.37 ± 1.48^f

48.75 ± 2.15^g

3.45 ± 0.13^b

6.47 ± 0.17^a

39.75 ± 2.13^c

50.25 ± 2.38^d,e

75.75 ± 3.59^d

3.20 ± 0.11^b

5.73 ± 0.17^b

34.30 ± 2.34^c,d